Transplacental transfer of Remdesivir and GS-441524: An ex vivo perfusion study

被引：0
|
作者：
Louchet, Margaux [1 ]
Ribot, Megane [1 ]
Bouazza, Naim [2 ]
Foissac, Frantz [2 ]
Froelicher, Leo [1 ]
Buth, Victoria [3 ]
Benaboud, Sihem [1 ]
Treluyer, Jean-Marc [1 ,2 ,3 ]
Lui, Gabrielle [1 ,3 ,4 ]
机构：
[1] Hop Cochin, Serv Pharmacol, Paris, France
[2] Hop Tarnier, AP HP, Unite Rech Clin, Paris, France
[3] CIC 1419 Mere Enfant Cochin Necker, Paris, France
[4] Hop Cochin, Serv Pharmacol, 27 Rue Faubourg St Jacques, F-75014 Paris, France
来源：
HEALTH SCIENCE REPORTS | 2023年 / 6卷 / 07期
关键词：
ex vivo cotyledon perfusion; GS-441524; placenta; Remdesivir; transplacental transfer; EXPRESSION; GENE;
D O I：
10.1002/hsr2.1144
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets
    Robert M. Cox
    Josef D. Wolf
    Carolin M. Lieber
    Julien Sourimant
    Michelle J. Lin
    Darius Babusis
    Venice DuPont
    Julie Chan
    Kim T. Barrett
    Diane Lye
    Rao Kalla
    Kwon Chun
    Richard L. Mackman
    Chengjin Ye
    Tomas Cihlar
    Luis Martinez-Sobrido
    Alexander L. Greninger
    John P. Bilello
    Richard K. Plemper
    Nature Communications, 12
  • [22] Pharmacokinetics of GS-441524, the active metabolite of remdesivir, in patients receiving continuous renal replacement therapy: A case series
    Nishikawa, Asami
    Ito, Isao
    Yonezawa, Atsushi
    Itohara, Kotaro
    Matsubara, Takeshi
    Sato, Yuki
    Matsumura, Katsuyuki
    Hamada, Satoshi
    Tanabe, Naoya
    Kai, Shinichi
    Imoto, Eishi
    Yoshikawa, Kohei
    Ohtsuru, Shigeru
    Yanagita, Motoko
    Hirai, Toyohiro
    Terada, Tomohiro
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (04) : 348 - 351
  • [23] Interpatient variability in the pharmacokinetics of remdesivir and its main metabolite GS-441524 in treated COVID-19 subjects
    Tempestilli, Massimo
    Ascoli Bartoli, Tommaso
    Benvenuto, Domenico
    Stazi, Giulia Valeria
    Marchioni, Luisa
    Nicastri, Emanuele
    Agrati, Chiara
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (10) : 2683 - 2687
  • [24] Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
    Tempestilli, Massimo
    Caputi, Priscilla
    Avataneo, Valeria
    Notari, Stefanie
    Forini, Olinda
    Scorzolini, Laura
    Marchioni, Luisa
    Bartoli, Tommaso Ascoli
    Castilletti, Concetta
    Lalle, Eleanore
    Capobianchi, Maria R.
    Nicastri, Emanuele
    D'Avolio, Antonio
    Ippolito, Giuseppe
    Agrati, Chiara
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (10) : 2977 - 2980
  • [25] Removal of Remdesivir's Metabolite GS-441524 by Hemodialysis in a Double Lung Transplant Recipient with COVID-19
    Le, Minh Patrick
    Le Hingrat, Quentin
    Jaquet, Pierre
    Wicky, Paul-Henri
    Bunel, Vincent
    Massias, Laurent
    Visseaux, Benoit
    Messika, Jonathan
    Descamps, Diane
    Mal, Herve
    Timsit, Jean-Francois
    Peytavin, Gilles
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (11)
  • [26] Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
    Ni, Xiaomin
    Schroeder, Martin
    Olieric, Vincent
    Sharpe, May E.
    Hernandez-Olmos, Victor
    Proschak, Ewgenij
    Merk, Daniel
    Knapp, Stefan
    Chaikuad, Apirat
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (04): : 603 - 609
  • [27] First analytical confirmation of drug-induced crystal nephropathy in felines caused by GS-441524, the active metabolite of Remdesivir
    Furbish, Amelia
    Allinder, Marissa
    Austin, Glenn
    Tynan, Beth
    Byrd, Emilee
    Gomez, Ivette Pina
    Peterson, Yuri
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2024, 247
  • [28] Population pharmacokinetic modeling of GS-441524, the active metabolite of remdesivir, in Japanese COVID-19 patients with renal dysfunction
    Sukeishi, Asami
    Itohara, Kotaro
    Yonezawa, Atsushi
    Sato, Yuki
    Matsumura, Katsuyuki
    Katada, Yoshiki
    Nakagawa, Takayuki
    Hamada, Satoshi
    Tanabe, Naoya
    Imoto, Eishi
    Kai, Shinichi
    Hirai, Toyohiro
    Yanagita, Motoko
    Ohtsuru, Shigeru
    Terada, Tomohiro
    Ito, Isao
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (01): : 94 - 103
  • [29] The Potential Protective Role of GS-441524, a Metabolite of the Prodrug Remdesivir, in Vaccine Breakthrough SARS-CoV-2 Infections
    JiaYi Zhu
    Yuchong Li
    Jady Liang
    Samira Mubareka
    Arthur S. Slutsky
    Haibo Zhang
    Intensive Care Research, 2022, 2 (3-4): : 49 - 60
  • [30] Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524
    Green, Jodie
    Syme, Harriet
    Tayler, Sarah
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2023, 37 (05) : 1784 - 1793
12345